These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14704463)

  • 1. Zonisamide: a new antiepileptic drug.
    Sobieszek G; Borowicz KK; Kimber-Trojnar Z; Małek R; Piskorska B; Czuczwar SJ
    Pol J Pharmacol; 2003; 55(5):683-9. PubMed ID: 14704463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between zonisamide and conventional antiepileptic drugs in the mouse maximal electroshock test model.
    Borowicz KK; Luszczki JJ; Sobieszek G; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):265-72. PubMed ID: 16876388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zonisamide: a new antiepileptic drug.
    Oommen KJ; Mathews S
    Clin Neuropharmacol; 1999; 22(4):192-200. PubMed ID: 10442247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to zonisamide.
    Baulac M
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S3-9. PubMed ID: 16413170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology and mechanism of action of zonisamide.
    Biton V
    Clin Neuropharmacol; 2007; 30(4):230-40. PubMed ID: 17762320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zonisamide in the treatment of epilepsy.
    Schulze-Bonhage A
    Expert Opin Pharmacother; 2010 Jan; 11(1):115-26. PubMed ID: 20001433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.
    Maschio M; Dinapoli L; Saveriano F; Pompili A; Carapella CM; Vidiri A; Jandolo B
    Acta Neurol Scand; 2009 Sep; 120(3):210-2. PubMed ID: 19719809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zonisamide for the treatment of epilepsy.
    Arzimanoglou A; Rahbani A
    Expert Rev Neurother; 2006 Sep; 6(9):1283-92. PubMed ID: 17009916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The new antiepileptic drugs: their indications and side effects].
    Malagón-Valdez J
    Rev Neurol; 2004 Sep 16-30; 39(6):570-5. PubMed ID: 15467997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation by zonisamide, a newer antiepileptic drug, of large-conductance calcium-activated potassium channel in differentiated hippocampal neuron-derived H19-7 cells.
    Huang CW; Huang CC; Wu SN
    J Pharmacol Exp Ther; 2007 Apr; 321(1):98-106. PubMed ID: 17255467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective audit of adjunctive zonisamide in an everyday clinical setting.
    Stephen LJ; Kelly K; Wilson EA; Parker P; Brodie MJ
    Epilepsy Behav; 2010 Apr; 17(4):455-60. PubMed ID: 20207201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
    Yamamura S; Ohoyama K; Nagase H; Okada M
    Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy.
    Levy RH; Ragueneau-Majlessi I; Garnett WR; Schmerler M; Rosenfeld W; Shah J; Pan WJ
    J Clin Pharmacol; 2004 Nov; 44(11):1230-4. PubMed ID: 15496640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide block of cloned human T-type voltage-gated calcium channels.
    Matar N; Jin W; Wrubel H; Hescheler J; Schneider T; Weiergräber M
    Epilepsy Res; 2009 Feb; 83(2-3):224-34. PubMed ID: 19124225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antiepileptic drugs--an overview.
    Sendrowski K; Sobaniec W
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():96-8. PubMed ID: 16119637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remacemide--a novel potential antiepileptic drug.
    Małek R; Borowicz KK; Kimber-Trojnar Z; Sobieszek G; Piskorska B; Czuczwar SJ
    Pol J Pharmacol; 2003; 55(5):691-8. PubMed ID: 14704464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.